Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants and antacids, aphrodisiac, atopic dermatitis, consumer division, cough and cold, muscle relaxants, n...
Jenburkt Pharmaceuticals reported revenue of 1.69 billion INR for fiscal year 2026, up 11.5% from fiscal year 2025, and net income of 347.36 million INR.
Figures from company filings; latest fiscal year ended March 31, 2026.
No profile data available.